European Commission 15 June 2016, Commission Implementing Regulation (EU) 2016/950 of 15 June 2016 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2,4-DB, beta-cyfluthrin, carfentrazone ethyl, Coniothyrium minitans Strain CON/M/91-08 (DSM 9660), cyazofamid, deltamethrin, dimethenamid-P, ethofumesate, fenamidone, flufenacet, flurtamone, foramsulfuron, fosthiazate, imazamox, iodosulfuron, iprodione, isoxaflutole, linuron, maleic hydrazide, mesotrione, oxasulfuron, pendimethalin, picoxystrobin, silthiofam and trifloxystrobin (Text with EEA relevance)
Also known as
European Union · · · Cited by 91 · 15-06-2016
16.6.2016
EN
Official Journal of the European Union
L 159/3
COMMISSION IMPLEMENTING REGULATION (EU) 2016/950
of 15 June 2016
amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2,4-DB, beta-cyfluthrin, carfentrazone ethyl, Coniothyrium minitans Strain CON/M/91-08 (DSM 9660), cyazofamid, deltamethrin,
Read the full text
This document is published by eur-lex.europa.eu.
Moonlit adds the citation network (91 references), article-level links and cross-references, which are available to search for free.
Sign in to Moonlit